calcium channel, voltage-dependent, gamma subunit 1 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
SIMVASTATIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
LEVAMISOLE |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
BECLOMETHASONE |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
DIFLUNISAL |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
NIFEDIPINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
NIFEDIPINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
NIFEDIPINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NIFEDIPINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
HYDROCORTISONE |
Serotonin 5-HT2A |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
CYTARABINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
CYTARABINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
DIFLORASONE DIACETATE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
CYTARABINE |
Imidazoline I2, Central |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CYTARABINE |
Imidazoline I2, Central |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
CILOSTAMIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
CILOSTAMIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
BRIMONIDINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
BRIMONIDINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
KETAMINE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
CYTARABINE |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CITRININ |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CITRININ |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
CITRININ |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CITRININ |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
CITRININ |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
CITRININ |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
ATORVASTATIN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
ATORVASTATIN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
ATORVASTATIN |
Platelet Activating Factor (PAF) |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
DIFLORASONE DIACETATE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
DICYCLOMINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DICYCLOMINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
ASPIRIN |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
ASPIRIN |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
ASPIRIN |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
ASPIRIN |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ATORVASTATIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
SULFABENZAMIDE |
Dopamine D3 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
GOLD SODIUM THIOMALATE |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
SULFABENZAMIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
BLEOMYCIN A2 |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
BLEOMYCIN A2 |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
URETHANE |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
CLOTRIMAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CHLORPROMAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
CHLORPROMAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
INSULIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
INSULIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
INSULIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
INSULIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
TIRILAZAD |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
TIRILAZAD |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
TIRILAZAD |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
CELECOXIB |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
CELECOXIB |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
RAPAMYCIN |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CLOBETASOL PROPIONATE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CLOMIPHENE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CLONAZEPAM |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CROTAMITON |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
CEPHALEXIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
CEPHALEXIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
COBALT (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
CLOFIBRIC ACID |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CLOFIBRIC ACID |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
CLOFIBRIC ACID |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
6(5H)-PHENANTHRIDINONE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
6(5H)-PHENANTHRIDINONE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
6(5H)-PHENANTHRIDINONE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
6(5H)-PHENANTHRIDINONE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
BENZO[E]PYRENE |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
CYCLOSPORIN A |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
CYCLOSPORIN A |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
CYCLOSPORIN A |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
CYCLOSPORIN A |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
BACITRACIN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
BACITRACIN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
BACITRACIN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
BACITRACIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
BISPHENOL A |
Serotonin 5-HT2A |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
BETA-ESTRADIOL 3-BENZOATE |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
BETA-ESTRADIOL 3-BENZOATE |
Adenosine A1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
CAPTOPRIL |
Adrenergic beta2 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BACITRACIN |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
PROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
PROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
3-ACETAMIDOPHENOL |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
3-ACETAMIDOPHENOL |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
cholecystokinin A receptor |
BETA-ESTRADIOL 3-BENZOATE |
Cholecystokinin CCKA |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
PROGESTERONE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
PROGESTERONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SIMVASTATIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
BECLOMETHASONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BECLOMETHASONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
PROPAFENONE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
PROPAFENONE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
DANAZOL |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
CEFOTAXIME |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
CAMPTOTHECIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
CAMPTOTHECIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
CAMPTOTHECIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
CAMPTOTHECIN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
DANAZOL |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
LY-294002 |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
R(-)-IBUPROFEN |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
DESLORATADINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
NETILMICIN |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
ACARBOSE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
ALENDRONIC ACID |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
MEDROXYPROGESTERONE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|